Ramachandran et al (84) reported that a 72-year-old patient with ALK-positive metastatic NSCLC developed acute kidney injury which necessitated emergency hemodialysis within 6-week treatment of alectinib. This evidence concerns the gene ALK and non-small cell lung carcinoma.